Novalis Lifesciences Investments
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- HQ
- NH
Novalis Capital Partners is a boutique investment and advisory firm focused on the life science industry. It invests in life science tools, diagnostics, and biopharma therapeutics companies. Its portfolio includes companies in animal health, cell and gene therapy manufacturing, agricultural biotechnology, molecular diagnostics, and drug discovery.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Biotech, Life sciences and research tools | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Novalis LifeSciences Investments II, L.P. Novalis Capital Partners makes direct venture capital and private equity investments in life science companies, focusing on life science tools, diagnostics, and biopharma therapeutics. It backs visionary life science entrepreneurs. Inferred from the firm's website | 2021 | $296.8M (Form D) | Late investment period |
03 · People across funds
- MARIJN DEKKERS
Novalis LifeSciences Investments II, L.P. (Named on Form D)
- PAUL MEISTER
Novalis LifeSciences Investments II, L.P. (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- https://www.novalislifesciences.com
- https://www.novalislifesciences.com/contact
- https://www.novalislifesciences.com/portfolio
- https://www.novalislifesciences.com/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026